VR-Assisted Rehabilitation in Partial Supraspinatus Tears
Effects of Virtual Reality-Assisted Rehabilitation on Pain, Kinesiophobia, Quality of Life, and Supraspinatus Tendon Thickness in Patients With Partial Supraspinatus Tears: A Randomized Controlled Trial
1 other identifier
interventional
52
1 country
1
Brief Summary
This randomized controlled trial investigated the effects of virtual reality-assisted rehabilitation in patients with partial supraspinatus tendon tears. Partial supraspinatus tears are a common cause of shoulder pain, functional limitation, restricted range of motion, and fear of movement. Conservative rehabilitation is commonly used as first-line treatment, while evidence regarding immersive virtual reality rehabilitation in this patient population remains limited. Participants were randomly allocated to either a virtual reality-assisted rehabilitation group or a conventional rehabilitation group. Both groups received the same physical therapy modalities, including hot pack, therapeutic ultrasound, and transcutaneous electrical nerve stimulation. The control group subsequently performed conventional therapeutic shoulder exercises, whereas the virtual reality group performed approximately equal-duration immersive VR-based exercises instead of the conventional exercise component. Outcomes included pain, shoulder range of motion, disability, kinesiophobia, health-related quality of life, and supraspinatus tendon thickness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedFirst Submitted
Initial submission to the registry
March 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedSeptember 15, 2026
September 1, 2026
12 months
March 12, 2026
September 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity measured by the Numeric Rating Scale (NRS)
Pain intensity at rest and during shoulder movement was assessed separately using an 11-point Numeric Rating Scale, ranging from 0 (no pain) to 10 (the worst pain imaginable). Higher scores indicated greater pain intensity.
Baseline and after 3 weeks of treatment
Secondary Outcomes (5)
Passive range of motion (ROM) of the affected shoulder
Baseline and after 3 weeks of treatment
Shoulder pain and disability measured using the Shoulder Pain and Disability Index (SPADI)
Baseline and after 3 weeks of treatment
Health-related quality of life measured using the Short Form-36 (SF-36)
Baseline and after 3 weeks of treatment
Kinesiophobia measured using the Tampa Scale of Kinesiophobia
Baseline and after 3 weeks of treatment
Supraspinatus tendon thickness measured using ultrasonography (USG)
Baseline and after 3 weeks of treatment
Study Arms (2)
virtual reality group
EXPERIMENTALParticipants received the same physical therapy modalities as the control group, consisting of hot pack, therapeutic ultrasound, and transcutaneous electrical nerve stimulation. They subsequently performed approximately 30 minutes of immersive virtual reality-based upper-extremity exercise using a Meta Quest Pro headset instead of the conventional therapeutic exercise component. The virtual reality exercise was therefore a replacement rather than an additional treatment.
Control Group
ACTIVE COMPARATORParticipants received physical therapy modalities consisting of hot pack, therapeutic ultrasound, and transcutaneous electrical nerve stimulation. They subsequently performed approximately 30 minutes of supervised conventional therapeutic shoulder exercises targeting shoulder mobility, stretching, strengthening, and scapular stabilization.
Interventions
Participants received physical therapy modalities consisting of hot pack, therapeutic ultrasound, and transcutaneous electrical nerve stimulation. They subsequently performed approximately 30 minutes of immersive virtual reality-based upper-extremity exercise using a Meta Quest Pro headset instead of the conventional therapeutic shoulder exercise component. The virtual reality activities involved repetitive, task-oriented shoulder and upper-extremity movements within an interactive three-dimensional environment. The intervention was delivered five days per week for three weeks, for a total of 15 sessions.
After receiving physical therapy modalities consisting of hot pack, therapeutic ultrasound, and transcutaneous electrical nerve stimulation, participants performed approximately 30 minutes of supervised conventional therapeutic shoulder exercise. The program included scapular mobilization; stretching exercises for shoulder flexion, abduction, internal rotation, and external rotation; and strengthening exercises for the shoulder and scapular stabilizer muscles. Exercises were performed in three sets of 10 repetitions. The intervention was delivered five days per week for three weeks, for a total of 15 sessions.
Eligibility Criteria
You may qualify if:
- Aged 18 to 65 years
- Shoulder pain persisting for more than four weeks
- Partial supraspinatus tendon tear confirmed by shoulder magnetic resonance imaging
You may not qualify if:
- Physiotherapy treatment within the previous six months
- Shoulder injection within the previous six months
- History of tendon repair surgery
- Communication or cognitive impairment
- Vertigo, vestibular disorder, or another condition causing balance instability
- History of epilepsy or seizures
- Photosensitivity
- Diagnosed psychiatric condition, including an anxiety disorder or claustrophobia
- Additional orthopedic condition affecting the same shoulder
- Neurological, vascular, or cardiac disorder restricting functional capacity
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
Study Sites (1)
Hitit University Erol Olçok Research Hospital Physical Medicine and Rehabilitation Clinic
Çorum, Çorum, 19000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 18, 2026
Study Start
January 1, 2025
Primary Completion
December 20, 2025
Study Completion
December 20, 2025
Last Updated
September 15, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to institutional regulations and the absence of participant consent for public data sharing.